ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      80.005
      0.00%
      Bitcoin
      103,318.21
      -0.78%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Radiopharm Theranostics Ltd (RADX) Quote

      Radiopharm Theranostics Ltd

      Radiopharm Theranostics Ltd (RADX)

      NASDAQ
      5.3405
      0.1505
      (2.90%)
      Closed January 18 4:00PM
      Delayed by 15 minutes
      5.3405
      0.00
      (0.00%)
      After Hours: 6:20PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      5.3405
      Bid
      4.73
      Ask
      5.88
      Volume
      186,548
      5.21 Day's Range 5.82
      0.00 52 Week Range 0.00
      Previous Close
      5.19
      Open
      5.21
      Last Trade
      50
      @
      5.74
      Last Trade Time
      Average Volume (3m)
      -
      Financial Volume
      $ 1,034,243
      VWAP
      5.5441

      Ask ADVFN Intelligence (AI)

      RADX Latest News

      More News

      Lantheus Increases to 12.16% shareholding in Radiopharm with US$5m (A$8m) Placement

      Private placement to radiopharmaceutical industry leader Lantheus, for US$5.0 millionPlacement at A$0.060 per share, representing a premium of 150% to the last closing price of A$0.024Lantheus...

      January 10 2025
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      January 10 2025
      Edgar (US Regulatory)

      Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

      RAD to advance the clinical development of Lantheus innovative radiopharmaceuticals in Australia Initial collaboration will focus on a Phase 1 imaging trialFinancial incentives to be paid to RAD...

      December 30 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 30 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 20 2024
      Edgar (US Regulatory)

      RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

      Ethics approval received in Australia for the initiation of RAD’s Phase 1 therapeutic trial of 177Lu-RAD202 in Breast and Gastric CancersThe Phase 1 First-In-Human study is designed to assess the...

      December 20 2024
      GlobeNewswire Inc.

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 19 2024
      Edgar (US Regulatory)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      December 18 2024
      Edgar (US Regulatory)

      Form EFFECT - Notice of Effectiveness

      December 16 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      December 13 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      RADX - Frequently Asked Questions (FAQ)

      What is the current Radiopharm Theranostics share price?
      The current share price of Radiopharm Theranostics is $ 5.3405
      What is the 1 year trading range for Radiopharm Theranostics share price?
      Radiopharm Theranostics has traded in the range of $ 0.00 to $ 0.00 during the past year

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BTCTBTC Digital Ltd
      $ 8.2697
      (73.73%)
      		61.45M
      BDMDBaird Medical Investment Holdings Ltd
      $ 8.80
      (62.36%)
      		18.63M
      CRKNCrown Electrokinetics Corporation
      $ 0.1235
      (54.96%)
      		764.86M
      NUKKNukkleus Inc
      $ 29.97
      (45.98%)
      		19.09M
      GSITGSI Technology
      $ 3.97
      (44.36%)
      		87.7M
      DOGZDogness International Corporation
      $ 18.23
      (-58.77%)
      		740.45k
      ORKTOrangeKloud Technology Inc
      $ 3.02
      (-24.88%)
      		21.08M
      PMAXPowell Max Ltd
      $ 0.6364
      (-23.31%)
      		4.17M
      LGCBLinkage Global Inc
      $ 0.2876
      (-22.27%)
      		890.66k
      YYAIConnexa Sports Technologies Inc
      $ 0.8299
      (-20.20%)
      		602.48k
      CRKNCrown Electrokinetics Corporation
      $ 0.1235
      (54.96%)
      		764.86M
      GCTKGlucoTrack Inc
      $ 0.0852
      (15.45%)
      		465.22M
      RIMEAlgorhythm Holdings Inc
      $ 0.0406
      (-4.02%)
      		387.23M
      TGLTreasure Global Inc
      $ 0.2459
      (14.75%)
      		267.1M
      NVDANVIDIA Corporation
      $ 137.71
      (3.10%)
      		201.4M

      RADX Discussion

      View Posts
      Invest-in-America Invest-in-America 1 month ago
      RADX: Whelp, for what it's worth, here's the new RADX iHub BOARD!!!! (They make cute DIAGNOSTIC --- & potentially THERAPEUTIC, as well --- Medical gadgets that can enter tiny, obscure, sites in our Homo sapiens BODIES; and then hopefully determine what-the-heck bad things are transpiring in there, & maybe fix them to boot!!!)
      👍️0

      Your Recent History

      NASDAQ
      RADX
      Radiopharm Theranostics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads